Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT02888665 · COMPLETED
Trial details
- NCT number
- NCT02888665
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2020-03-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.